Advanced search
Publication Cover
Acta Cardiologica Volume 76, 2021 - Issue 1
Submit an article Journal homepage
54
Views
2
CrossRef citations to date
0
Altmetric
Original Scientific Paper

Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure

Xi ChenDepartment of Cardiology, Affiliated Hospital of Putian University, Putian, Fujian, ChinaORCID Iconhttps://orcid.org/0000-0002-5978-1388View further author information
ORCID Icon,
Meifang WuDepartment of Cardiology, Affiliated Hospital of Putian University, Putian, Fujian, ChinaCorrespondence[email protected]
View further author information
,
Kaizu XuDepartment of Cardiology, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information
,
Meinv HuangDepartment of Cardiology, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information
&
Xiuping ZhuoDepartment of Cardiology, Affiliated Hospital of Putian University, Putian, Fujian, ChinaView further author information
Pages 87-92 | Received 15 Apr 2020, Accepted 11 May 2020, Published online: 10 Jun 2020

References

  • Ritzema J, Troughton R, Melton I, et al. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation. 2010;121:1086–1095.
  • Donkor A, Cleland J, McDonagh T, et al. National Heart Failure Audit 2016 11.07.2016.
  • Demissei BG, Cotter G, Prescott MF, et al. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. Eur J Heart Fail. 2017;19:1001–1010.
  • Domingo PF. Acute heart failure and biomarkers: time also matters, don't relax. Eur J Heart Fail. 2017;19:1011–1013.
  • Charmetant X, Pecquet M, Poirié P, et al. Impact of age and renal function on usefulness of NT-proBNP to diagnose heart failure. CN. 2019;92:65–72.
  • Hung CL, Hung TC, Lai YH, et al. Beyond malignancy: the role of carbohydrate antigen 125 in heart failure. Biomark Res. 2013;1:25.
  • Núñez J, Llàcer P, Bertomeu-González V, et al.; CHANCE-HF Investigators. Carbohydrate antigen-125-guided therapy in acute heart failure: CHANCE-HF: a randomized study. JACC Heart Fail. 2016;4:833–843.
  • García-Blas S, Bonanad C, Llàcer P, et al.; IMPROVE-HF Investigators. Diuretic strategies in acute heart failure and renal dysfunction: conventional vs carbohydrate antigen 125-guided strategy. Clinical trial design. Rev Esp Cardiol (Engl Ed). 2017;70:1067–1073.
  • Li KHC, Gong M, Li G, et al.; On behalf of International Health Informatics Study (IHIS) Network. Cancer antigen-125 and outcomes in acute heart failure: a systematic review and meta-analysis. Heart Asia. 2018;10:e011044.
  • Gerszten RE, Wang TJ. The search for new cardiovascular biomarkers. Nature. 2008;451:949–952.
  • Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37:2129–2200.
  • Kurmani S, Squire I. Acute heart failure: definition, classification and epidemiology. Curr Heart Fail Rep. 2017;14:385–392.
  • Parrinello G, Torres D, Paterna S, et al. The pathophysiology of acute heart failure: the key role of fluid accumulation. Am Heart J. 2008;156:e19.
  • Noveanu M, Breidthardt T, Potocki M, et al. Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure. Crit Care. 2011;15:R1.
  • Huang F, Chen J, Liu Y, et al. New mechanism of elevated CA125 in heart failure: the mechanical stress and inflammatory stimuli initiate CA125 synthesis. Med Hypotheses. 2012;79:381–383.
  • Núñez J, Núñez E, Bayés-Genís A, et al. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure. Eur Heart J Acute Cardiovasc Care. 2017;6:685–696.
  • Mihai G, Ferenc F, Piotr P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010;12:423–433.
  • van den Berge JC, Constantinescu AA, van Domburg RT, et al. Renal function and anemia in relation to short- and long-term prognosis of patients with acute heart failure in the period 1985-2008: a clinical cohort study. PLoS ONE. 2018;13:e0201714.
  • Medina F, Franco J, Huerta J, et al. [Atrial fibrillation in acute heart failure: clinical features and prognosis]. Semergen. 2018;44:e98–e100.
  • Campo G, Pavasini R, Biscaglia S, et al. Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease. Eur Heart J Cardiovasc Pharmacother. 2015;1:205–211.
  • Nunez J, Sanchis J, Bodí V, et al. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure. Eur Heart J. 2010;31:1752–1763.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.